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Abstract 
 
Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most complicated 
problems in infection control and disease prevention. Imported strains or group of 
similar strains called clones were introduced from other states within Australia and also 
from other countries. Western Australia (WA) MRSA clones known to be the most 
predominant clones circulating in Western Australia (WA). However, MRSA strains 
originally from other states and countries outside Australia (imported) have increased 
in number in the last decades. The aim of this study was to examine the epidemiology 
of CA MRSA clones in Western Australia for the past 11 year’s period (2003-2013). There 
were 10 predominant clones of CA-MRSA circulating in WA with WA MRSA-1 (32,82%), 
Queensland (22,67 %) and WA MRSA-2 (22,67 %) clones as the top three predominant 
clones. The percentage of PVL positive CA-MRSA clones such as Queensland (Qld) 
clone has been increasing significantly (R2=0,67) from 2,38 % in 2002 to 25,69% in 2013. 
In contrast, the percentages of two major PVL negative clones, WA MRSA-1 and WA 
MRSA 2, have been decreasing nearly by half from 52,38 % to 27,71 % and 30,95 % to 
16,59 % respectively in the last 11 years. PVL positive clones have been introduced in 
WA from other states and overseas in the last eleven years. Due to the virulence factor 
of PVL toxin, the emergence of PVL positive CA-MRSA should be considered as public 
health concerns. 
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1.0  INTRODUCTION 
 
Staphylococcus aureus are the most common 
bacteria that can cause infections in all parts of 
human body such as in the skin, soft tissue, 
bloodstream, respiratory and urinary tract. 
Staphylococcus aureus can also be found in almost 
all geographic areas. Methicillin-resistant 
Staphylococcus aureus (MRSA) is one of the most 
complicated problems in infection control and 
disease prevention in hospital and health care 
setting (1). According to the pattern of antimicrobial 
resistance, there were two groups of MRSA circulated 
in Western Australia that can be classified as multi 
drug-resistant imported clones and less drug-resistant 
clones (WA MRSA) (2). Imported strains or group of 
similar strains called clones were introduced from 
other states within Australia and also from other 
countries. WA MRSA clones known to be the most 
predominant clones circulating in Western Australia 
(WA). However, MRSA strains originally from other 
states and countries outside WA (imported) has been 
increasing in number in the last decades (3). 
Clonal types of CA MRSA circulated in Australia 
were quite diverse compare to other countries. In 
United States for example, USA300 MRSA clones 
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counted at least  70 % as the cause of skin and soft 
tissue infections (4). A multicenter study about 
genetic diversity among Community-Acquired (CA) 
MRSA in Europe showed USA300 clones were the 
predominant clones (40 %) circulated in several 
countries in Europe (5). In contrast, there were at 
least 59 clones of CA MRSA in Australia have been 
identified (6). The diversity of CA MRSA clones 
increasing in number over the last two decades. 
Most of the new clones were originally from overseas 
which imported from other countries and then 
established in Australia.   
Generally, imported clones have higher virulence 
properties compared to MRSA clones originated from 
WA (WA MRSA). One of the virulence properties is 
called Pantone-Valentine Leukocidine (PVL). A PVL 
positive MRSA clones have emerged as a cause of 
both hospital-acquired (HA) and community-
acquired (CA) infections in Western Australia (7). CA 
MRSA accounted for around 70 % while HA MRSA 30 
% from all MRSA infections in Australia. A significant 
increase of CA MRSA has been reported between 
1998 and 2002 in Western Australia (3). In 2013, 
Kimberly region accounted having the highest CA-
MRSA colonisation rates in Western Australia 
(2,176/100,000 population) (8). The aim of this study 
was to examine the epidemiology of CA MRSA 
clones in Western Australia for the past 11 year’s 
period (2003-2013)  
 
 
2.0  METHODOLOGY 
 
A systematic review was performed to identify 
eligible articles. The MEDLINE database from 2002 to 
2013 was collected by combining words of “clones”, 
“MRSA”, “Methicillin-Resistant”, “Staphylococcus 
aureus”, “epidemiology” and “Western Australia”. 
Only articles reporting the epidemiology of CA-MRSA 
clones in Western Australia were included. 
 
 
3.0  RESULTS AND DISCUSSION 
 
In the past 11 years, 9 studies were conducted to 
analysis the clones of CA-MRSA circulating in WA with 
a total 15.512 isolates. Among these isolates, there 
were 10 predominant clones of CA-MRSA circulating 
in WA as seen in Figure 1; WA MRSA-1 (32,82%), 
Queensland (22,67 %), WA MRSA-2 (22,67 %), WA 
MRSA-3 (9,86 %), WSPP MRSA (4,81%), WA MRSA-121 
(1,85 %), USA300 (1,64%), Taiwan CA-MRSA (0,72%), 
Bengal Bay (0,61 %) and WA MRSA-62 (0,49 %).  
 
 
 
Figure 1 Percentages of five predominant MRSA clones 
circulated in WA from 2002 to 2013 
 
 
Figure 2 shows the trend of 5 major clones of CA-
MRSA in WA in the past 11 years. The percentages of 
PVL positive CA-MRSA clones such as Queensland 
(Qld) clone has been increasing significantly 
(R2=0,67) from 2,38 % in 2002 to 25,69% in 2013. In 
contrast, the percentages of two major PVL negative 
clones, WA MRSA-1 and WA MRSA 2, have been 
decreasing nearly by half from 52,38 % to 27,71 % 
and 30,95 % to 16,59 % respectively in the last 11 
years (6-11). Of five predominant CA MRSA clones (n 
= 13.709 isolates), There were 3 CA WA-MRSA and 2 
imported CA MRSA identified as the top five 
predominant clones in the last 11 years. The average 
percentages of CA WA-MRSA and imported CA 
MRSA were 76,09 % (n = 9.446 isolates) and 19,36 % (n 
= 4.263 isolates) respectively. 
 
 
 
Figure 2 Average percentages of CA MRSA clones in WA 
within 11 years 
 
 
Staphylococcus aureus can be found in the 
surface of human bodies and has the ability to 
develop antimicrobial resistance by acquiring 
resistance gene from other resistant strains. S. aureus 
resistance to methicillin were discovered not too long 
after methicillin being used in 1960. Since that time, 
several outbreaks have been reported around the 
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world including in Australia in 1976. The MRSA strains 
that caused different outbreaks around the world 
were thought to be genetically different according 
to the geographical area where those particular 
strains have emerged. However, after the 
application of multilocus sequence typing (MLST) 
combined with Staphylococcal chromosome 
cassete mec (SCCmec) typing by Enright et al. in 
2002, there were only several major MRSA clones 
known to be circulated around the world (12).  
First MRSA cases in Western Australia were 
discovered in 1982 when there was an outbreak in a 
teaching hospital. The outbreak was occurred in 
Royal Perth Hospital after the admission of patient 
with MRSA infection from other states (13). The MRSA 
strain from this outbreak was categorized as 
imported strains and called as epidemic MRSA 
(EMRSA) because from the genetic analysis of the 
isolates showed that these strains were similar to the 
first MRSA strains isolated in Eastern Australia in 1976 
called Eastern Australian MRSA (EA MRSA) (14).  
MRSA colonisations have become a notifiable 
disease in WA since there were an MRSA outbreak in 
1982. Following this, MRSA stewardship program has 
been activated to prevent imported strains of MRSA 
to become established in any hospital within WA. The 
policy require all patients who had been treated in 
any hospital outside WA in the previous 12 months 
should be screened for MRSA carriage (13, 14). This 
policy also require MRSA screening to all health care 
workers who have been working outside WA in the 
previous 12 months before working in WA health care 
services. This policy was very useful to prevent the 
establishment of epidemic MRSA strains in WA 
hospitals and other health care services (15).  
In 1990, there was an increase in number of MRSA 
infections in Perth area. Most of the patients never 
been to any places outside WA. In fact, most of the 
patients were originally from Kimberly region of 
northern WA. The genetic analysis of the isolates 
revealed that this MRSA incidences was caused by 
new non-multidrug resistant MRSA strains and differ to 
the earlier strains (EA MRSA) (14). This finding can be 
considered as the early cases involving WA MRSA 
strains in WA. However, some WA MRSA strains then 
evolved and acquired multi-drug resistance plasmids 
which encode resistance properties to antimicrobials. 
Community acquired MRSA can be found in any 
form of infections from minor skin and soft tissue 
infections to bacteremia with sepsis. There were no 
significant differences between CA MRSA and HA 
MRSA in term of severity of illness. In addition, CA 
MRSA clones were interestingly found to be the most 
predominant causes of HA MRSA bacteremia in 
some studies and it’s even higher compare to HA 
MRSA clones itself  (16). A screening study conducted 
by Dailey et al. (2005) revealed that WA MRSA were 
the predominant CA MRSA strains circulated in WA 
between 1998 and 2002. Overall, there were three 
CA WA MRSA clones (ST1-MRSA, ST129-MRSA and ST5-
MRSA) circulated in Western Australia during this 
period. However, there was a significant increase in 
the incidence of imported MRSA strains from 6,4 % 
notifications in 1998 to 24,4 % in 2002 (3). Even though 
the number of WA MRSA strains incidences were 
increasing during this period, the ratio between WA 
MRSA strains to imported MRSA strains was 
decreased. 
There were 9 epidemiological studies conducted in 
the last 11 years in WA which examining the diversity 
of CA MRSA clones. In total, 15.512 isolates of CA 
MRSA were examined using similar techniques and 
methods to identify the genetic properties of each 
isolates. Pulsed-field gel electrophoresis (PFGE), spa 
typing, multi locus sequence typing (MLST) and PCR 
test for detecting staphylococcal cassette 
chromosome mec (SCCmec) elements and Panton-
Valentine Leukocidin (PVL) were used to determine 
the characteristic of each isolates and differentiate 
into different clones.  
The results from this study show similar patterns with 
the previous studies. WA MRSA-1 clones remain the 
most predominant CA MRSA clones isolated in WA 
from 2002 to 2013. Of the top five predominant 
clones (n=13.709 isolates) circulated in WA between 
2002 and 2013, three CA WA-MRSA clones (ST1-MRSA, 
ST129-MRSA and ST5-MRSA) and two imported CA 
MRSA clones were identified (Qld and WSPP MRSA 
clones). The average percentages of CA WA-MRSA 
and imported CA MRSA clones counted as many as 
76,09 % (n = 9.446 isolates) and 19,36 % (n = 4.263 
isolates) respectively. Figure 3 provides the 
comparison of the percentages between CA WA-
MRSA clones and imported MRSA clones in the last 11 
years. There were an increasing number of imported 
CA MRSA clones from 2002 (5,76 %) to 2013 (37,32 %). 
In contrast, the percentages of CA WA-MRSA clones 
have been decreased nearly by half from 95,23 % in 
2002 to become 54,72 % in 2013.  
WA MRSA clones known to be less drug-resistant 
clones compared to imported MRSA clones.  
Generally, WA MRSA clones were not carry the gene 
encoding Panton–Valentine leukocidin (PVL). PVL is a 
toxin that capable to create polymeric pores in 
leukocyte membrane (2). Most of PVL positive strains 
isolated from abscess and furunculoses were resistant 
to many antimicrobial drugs especially from β-
Lactam groups. In contrast, PVL negative strains 
usually less resistant and easy to treat (17, 18). 
The ratio between WA CA-MRSA and imported CA-
MRSA as seen in Figure 3 shows how the 
establishment of imported CA-MRSA has been 
changed in the last decades. It is poorly understood 
why the population of imported CA-MRSA are 
increasing. Regarding the acquisition of PVL 
encoding gene (PVL positive clones), all three WA 
CA-MRSA clones were PVL negative while all two 
imported CA-MRSA clones were PVL positive. It can 
be assume that the increase of imported CA-MRSA 
clones circulating in WA implicate to the increase of 
virulent MRSA strains population. 
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Figure 3 Percentages of WA and non-WA CA-MRSA clones 
circulated in WA from 2002 to 2013 
 
 
4.0  CONCLUSION 
 
In conclusion, WA CA-MRSA still become the most 
predominant clones circulating in WA in the last 11 
years. There were an increasing number of imported 
CA MRSA clones circulated in WA. PVL positive, 
Queensland, MRSA clones were increasing in number 
of incidences in WA between 2002 and 2013. Most of 
WA MRSA clones were PVL negative while most of 
imported clones were PVL positive clones. PVL 
encoded gene could be transmitted from PVL 
positive clones to PVL negative clones and increase 
the virulence of WA MRSA clones. PVL proteins will 
increase the morbidity of MRSA colonization and 
infection in a patient as it cause leukocyte 
destructions and necrotic lesions. PVL positive clones 
have been introduced in WA from other states and 
overseas in the last eleven years. Due to the 
virulence factor of PVL toxin, the emergence of PVL 
positive CA-MRSA should be considered as public 
health concerns. MRSA stewardship policy could 
prevent the establishment of PVL positive CA MRSA 
clones in hospital and health care services. However, 
similar policy and program should be delivered to 
community in order to prevent the establishment of 
PVL positive MRSA clones in community.  
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